Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors Meeting Abstract
| Authors: | Strosberg, J. R.; Caplin, M. E.; Kunz, P. L.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A. E.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; Grande, E.; Van Cutsem, E.; Seregni, E.; Duarte, H.; Gericke, G.; Bartalotta, A.; Demange, A.; Mutevelic, S.; Krenning, E.; on behalf of the NETTER-1 study group |
| Abstract Title: | Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602212 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4112 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4112 -- Source: Wos |
